Literature DB >> 21053000

[Calciphylaxis. A less well-known, clinically relevant disease].

J D Strehl1, V Brandenburg, C Forster, C Willam, A Hartmann, K Amann.   

Abstract

Calciphylaxis is a rare disease which has been increasingly reported in recent decades and has consequently shifted into the focus of clinical and scientific research. The clinical picture is characterized by extensive ischemic ulcerations of the skin and subcutis. Histologically, the small vessels in these lesions show prominent calcifications. Due to the extensive areas of ulceration and necrosis as well as frequently present comorbidities, patients with calciphylaxis are prone to infection and sepsis. In this work, we describe the case of a female kidney-transplant patient with vasculitis who, despite good graft function, developed a fulminant calciphylaxis of both thighs 4 years post transplantation and died of septic complications. The differential diagnoses as well as clinical procedures are described in detail in the case history. In the discussion, we give an overview of the current state of knowledge regarding the etiopathogenesis, risk factors, diagnostic measures and clinical management of calciphylaxis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21053000     DOI: 10.1007/s00292-010-1411-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  37 in total

1.  Calciphylaxis: natural history, risk factor analysis, and outcome.

Authors:  Roger H Weenig; Lindsay D Sewell; Mark D P Davis; James T McCarthy; Mark R Pittelkow
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

Review 2.  Calcific uremic arteriolopathy: advances in pathogenesis and treatment.

Authors:  Natasha M Rogers; David J O Teubner; P Toby H Coates
Journal:  Semin Dial       Date:  2007 Mar-Apr       Impact factor: 3.455

3.  Fulminant pulmonary calciphylaxis and metastatic calcification causing acute respiratory failure in a uremic patient.

Authors:  Yi-Jung Li; Ya-Chung Tian; Yung-Chang Chen; Shiu-Feng Huang; Chung-Chi Huang; Ji-Tseng Fang; Chih-Wei Yang
Journal:  Am J Kidney Dis       Date:  2006-04       Impact factor: 8.860

4.  Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy.

Authors:  Adrian Fine; James Zacharias
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

5.  Calciphylaxis in patients on hemodialysis: a prevalence study.

Authors:  M Angelis; L L Wong; S A Myers; L M Wong
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

6.  Intestinal ischemia and peripheral gangrene in a patient with chronic renal failure.

Authors:  Jesús Rivera-Nieves; Giorgos Bamias; Jonathan Alfert; Stephen J Bickston; Christopher A Moskaluk; Fabio Cominelli
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

7.  Calciphylaxis associated with rheumatoid arthritis: communication of the second case.

Authors:  Alberto Ortiz; Federico Ceccato; Susana Roverano; Adriana Albertengo; Sergio Paira
Journal:  Clin Rheumatol       Date:  2009-03-19       Impact factor: 2.980

Review 8.  Calciphylaxis from nonuremic causes: a systematic review.

Authors:  Sagar U Nigwekar; Myles Wolf; Richard H Sterns; John K Hix
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

Review 9.  Vitamin K-dependent proteins, warfarin, and vascular calcification.

Authors:  John Danziger
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 8.237

Review 10.  Cutaneous necrosis from calcific uremic arteriolopathy.

Authors:  T Coates; G S Kirkland; R B Dymock; B F Murphy; J K Brealey; T H Mathew; A P Disney
Journal:  Am J Kidney Dis       Date:  1998-09       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.